Kane Biotech (TSE:KNE) has released an update.
Kane Biotech has secured its first distribution agreement in the Middle East, partnering with Razan Medical Trading to bring its revyve™ Antimicrobial Wound Gel to the United Arab Emirates’ wound care market. This marks the company’s third distribution deal, following previous agreements in the US and parts of Latin America, showcasing its commitment to expanding commercialization on a global scale.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
